News | April 22, 2015

Higher field strength improves image quality but raises concerns about radiation dose to the fetus

April 22, 2015 — Although ultrasound remains the primary imaging modality used in prenatal imaging, fetal magnetic resonance imaging (MRI) is playing an increasing role in further evaluation of fetuses suspected of congenital anomalies. As 3-T MRI scanners become more common due to their improved image signal-to-noise ratio and anatomical detail, the benefits of 3-T MRI must be weighed against potential risks to the fetus that may result from the higher field strength.

"MRI is playing an increasingly important role in the assessment of complex prenatal disease," said Kathleen E. Carey, M.D., Mayo Clinic, Jacksonville, Florida. "The use of stronger 3-T field strengths may allow for improved visualization of subcutaneous fat and osseous structures, including the hands and feet of the developing fetus."

The study is featured in an electronic exhibit at the American Roentgen Ray Society (ARRS) 2015 annual meeting in Toronto.

First attempted in the 1980s, MRI in pregnancy has maintained a steady growth rate. Recent studies have demonstrated that fetal MRI not only provides good detail of normal fetal anatomy and allows characterization of suspected anomalies but also may alter the diagnosis provided by ultrasound, uncovering fetal anomalies earlier and more accurately. Currently, clinical MRI is most frequently performed on 1.5-T MRI systems, but 3-T scanners are becoming more common around the world as the search for improved image signal-to-noise ratio and anatomic detail grows. This developmental opportunity must be weighed against potential risks to the fetus, taking into account the specific absorption rate.

ARRS will present a series of fetal MRI cases and discuss the anatomic and imaging findings, indication for MRI, diagnosis and impact on patient management. The benefits and limitations of fetal MRI at 1.5-T and 3-T field strengths will be discussed, and future advanced imaging will be considered, including spectroscopy and diffusion tensor imaging.

For more information: www.arrs.org


Related Content

News | FDA

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating ...

Time October 07, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
News | Radiology Imaging

Aug. 13, 2026 — Epic's new Care Everywhere Diagnostic Image Exchange allows health systems using Epic to share ...

Time August 21, 2026
arrow
News | Cardiac Imaging

Aug. 20, 2026 – The novel, radiopaque, polymer-based embolic coil from Embolization, Inc. has now surpassed 125 implants ...

Time August 20, 2026
arrow
News | Radiology Business

Aug. 4, 2026 — Canon Medical Systems USA (CMSU) has appointed Tsuneo "Neo" Imai as president and chief executive officer ...

Time August 10, 2026
arrow
News | Radiology Imaging

Aug. 4, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that the time between an imaging scan ...

Time August 06, 2026
arrow
News | Contrast Agents

Aug. 5, 2026 — Bracco Group is bringing a newly authorized macrocyclic gadolinium-based contrast agent (GBCA) for ...

Time August 05, 2026
arrow
News | Neuro Imaging

July 9, 2026 — Viz.ai has announced a collaboration with Cortechs.ai to integrate Cortechs.ai's NeuroQuant and ...

Time July 10, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
Subscribe Now